| Allen Leavitt, PHARMD | |
|
451 4th St, Ketchum, ID 83340 | |
| (208) 726-2596 | |
| (208) 726-8268 |
| Full Name | Allen Leavitt |
|---|---|
| Gender | Male |
| Speciality | Pharmacist |
| Location | 451 4th St, Ketchum, Idaho |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1477982411 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 183500000X | Pharmacist | P6867 (Idaho) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Allen Leavitt, PHARMD Po Box 9200, Ketchum, ID 83340-7143 Ph: (208) 726-2596 | Allen Leavitt, PHARMD 451 4th St, Ketchum, ID 83340 Ph: (208) 726-2596 |
News Archive
With positron emission tomography (PET) imaging, seeing is believing: Evaluating a patient's response to chemotherapy for non-Hodgkin lymphoma (NHL) typically involves visual interpretation of scans of cancer tumors.
A new study from the University of Surrey has found that 4-weeks of daily galacto-oligosaccharides (GOS) prebiotic intake can reduce anxiety levels and result in an overall improvement in wellbeing in young women.
The true power of genomic research lies in its ability to help scientists understand biological processes, particularly those that - when altered - can lead to disease. This power is demonstrated dramatically in a pair of papers published today in the journal Nature. In the first, a global team of researchers describes 95 different variations across the genome that contribute in different degrees to alterations in blood cholesterol and triglyceride levels in multiple human populations. In the second report, close examination of just one of these common variants not only reveals the involvement of an unexpected genetic pathway in lipid metabolism but also provides a blueprint for using genomic findings to unravel biological connections between lipid levels and coronary heart disease.
Pfizer Inc. announced that top-line results of a double-blind, Phase 3 study evaluating pregabalin controlled-release (CR) formulation in patients with fibromyalgia indicate that pregabalin CR had a statistically significant positive effect compared to placebo in the primary endpoint, time to loss of therapeutic response (LTR).
A few days ago, the European Commission presented its Green Deal, which aims to make the EU climate neutral by 2050 in order to protect the environment and improve people's health and quality of life.
› Verified 2 days ago
Mr. Eugene Walter Steiner, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 451 4th St, Ketchum, ID 83340 Phone: 208-726-5696 Fax: 208-726-8268 | |
Ellen Patricia Schulz, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 451 4th St, Ketchum, ID 83340 Phone: 208-726-2596 Fax: 208-726-8268 | |
Catherine Swink, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 201 N. Washington Ave, Ketchum, ID 83340 Phone: 208-726-2679 Fax: 208-726-1179 | |
Jon J Holmquist, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 100 Hospital Drive, Ketchum, ID 83340 Phone: 208-727-8300 Fax: 208-727-8304 | |
Lorena Mcclusky, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 100 Hospital Dr, Ketchum, ID 83340 Phone: 208-727-8300 | |
Dr. Abram Joseph Guard, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 451 4th Street, Ketchum, ID 83340 Phone: 208-269-0611 |